跳至主要内容
临床试验/NL-OMON39800
NL-OMON39800已完成4 期

Prospective, randomized, open label trial of six vs. twelve months dual antiplatelet therapy after drug-eluting stent implantation in ST-elevation myocardial infarction. - DAPT-STEMI

Maasstadziekenhuis0 个研究点目标入组 580 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
580

研究概览

简要总结

Trial is onging in other countries

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • STEMI patients between 18-85 years, who underwent PCI with second generation DES implantation

排除标准

  • Key Exclusion Criteria Enrollment: Intolerance to Aspirin, Plasugrel, Ticagrelor, Heparin, Bivaluridin, Everoliumus or Zotarolimus.
  • Known bleeding diathesis or known coagulopathy.
  • Planned elective surgical procedure necessitating interruption of dual antiplatelet therapy during the first 6 months after randomization.;Key Exclusion Criteria Randomization:
  • Occurrence of death, myocardial infarction, stent thrombosis and target vessel or lesion revascularization during the first 6 months after inclusion.
  • Stroke or bleeding requiring discontinuation of DAPT during the first 6 months after inclusion.
  • Oral anticoagulant therapy with coumarin derivates.

研究者

发起方
Maasstadziekenhuis

相似试验

已完成
2 期
A randomized, open-label, parallel-group, multi-center study of adding edoxaban or clopidogrel to aspirin to maintain patency in subjects with peripheral arterial disease following femoropopliteal endovascular intervention-edoxaban in peripheral arterial disease (ePAD)narrowing of the peripheral arteries (mostly in the legs)periferal arterial disease10003216
NL-OMON40071Daiichi Sankyo Development Ltd14
已完成
4 期
A randomised, open-label clinical trial assessing the efficacy and safety of mycophenolate mofetil versus azathioprine for induction of remission in treatment naive autoimmune hepatitis1001965410003816Autoimmune hepatitis
NL-OMON52983eids Universitair Medisch Centrum66
已完成
3 期
A randomised, open-label clinical trial assessing the efficacy of octreotide to decrease iron infusion and blood transfusion requirements in patients with refractory anaemia due to gastrointestinal bleeding from angiodysplasias.angiodysplasiavascular malformation10017959
NL-OMON44271Maag-, darm- en leverziekten62
已完成
不适用
An open-label, adaptive multiple-dose study to investigate the pharmacokinetics and pharmacodynamics of RO7234292 in csf and plasma, and safety and tolerability following intrathecal administration in patients with Huntington's disease.Chronic Progressive Choreadegenerative chorea1002929910029317
NL-OMON49037Hoffmann-La Roche4
已完成
2 期
A randomised, controlled, double-blind trial to investigate the effects of a new infant formula on growth, tolerance and safety in healthy term infants.effect op de groei van zuigelingeneffects on growth
NL-OMON39783utricia Research - Centre for Specialised Nutrition121